KR20090059152A - 쿠프레독신으로 암을 예방하는 조성물과 방법 - Google Patents

쿠프레독신으로 암을 예방하는 조성물과 방법 Download PDF

Info

Publication number
KR20090059152A
KR20090059152A KR1020097007352A KR20097007352A KR20090059152A KR 20090059152 A KR20090059152 A KR 20090059152A KR 1020097007352 A KR1020097007352 A KR 1020097007352A KR 20097007352 A KR20097007352 A KR 20097007352A KR 20090059152 A KR20090059152 A KR 20090059152A
Authority
KR
South Korea
Prior art keywords
ala
cupredoxin
gly
cancer
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020097007352A
Other languages
English (en)
Korean (ko)
Inventor
타파스 다스 구프타
아난다 차카라바티
Original Assignee
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 filed Critical 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이
Publication of KR20090059152A publication Critical patent/KR20090059152A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020097007352A 2006-09-14 2007-09-13 쿠프레독신으로 암을 예방하는 조성물과 방법 Withdrawn KR20090059152A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
US60/844,358 2006-09-14

Publications (1)

Publication Number Publication Date
KR20090059152A true KR20090059152A (ko) 2009-06-10

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097007352A Withdrawn KR20090059152A (ko) 2006-09-14 2007-09-13 쿠프레독신으로 암을 예방하는 조성물과 방법

Country Status (13)

Country Link
EP (1) EP2061498A4 (cg-RX-API-DMAC7.html)
JP (2) JP2010503409A (cg-RX-API-DMAC7.html)
KR (1) KR20090059152A (cg-RX-API-DMAC7.html)
CN (1) CN101595124A (cg-RX-API-DMAC7.html)
AU (1) AU2007296429A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0714987A2 (cg-RX-API-DMAC7.html)
CA (1) CA2663498A1 (cg-RX-API-DMAC7.html)
IL (1) IL197602A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009002787A (cg-RX-API-DMAC7.html)
NO (1) NO20091267L (cg-RX-API-DMAC7.html)
RU (1) RU2009113812A (cg-RX-API-DMAC7.html)
SG (1) SG174784A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008033987A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
UA97466C2 (ru) 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
US8232244B2 (en) 2007-02-08 2012-07-31 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
EP1904642A4 (en) 2005-07-19 2008-11-26 Univ Illinois TRANSPORT AGENTS FOR CROSS-BREAKING BLOOD-BRAIN DISEASE AND INTRUSION IN BRAIN CANCER CELLS AND METHOD OF USE THEREOF
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
CA3075836A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
UA97466C2 (ru) * 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Also Published As

Publication number Publication date
JP2010503409A (ja) 2010-02-04
WO2008033987A3 (en) 2009-04-30
AU2007296429A1 (en) 2008-03-20
CN101595124A (zh) 2009-12-02
SG174784A1 (en) 2011-10-28
JP2014050390A (ja) 2014-03-20
MX2009002787A (es) 2009-08-27
CA2663498A1 (en) 2008-03-20
IL197602A0 (en) 2011-08-01
RU2009113812A (ru) 2010-10-20
WO2008033987A2 (en) 2008-03-20
EP2061498A2 (en) 2009-05-27
EP2061498A4 (en) 2009-11-04
BRPI0714987A2 (pt) 2013-07-30
NO20091267L (no) 2009-06-04

Similar Documents

Publication Publication Date Title
CN101595124A (zh) 使用铜氧还蛋白预防癌症的组合物及方法
US10117905B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10086037B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10351605B2 (en) Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways
US20180319848A1 (en) Modifications of cupredoxin derived peptides and methods of use thereof
CN102316887A (zh) 用铜氧还蛋白预防癌症的组合物和方法
KR20080019615A (ko) 쿠프레독신과 시토크롬으로 말라리아를 치료하기 위한조성물과 방법
KR20080024124A (ko) 쿠프레독신과 시토크롬 c로 hiv 감염을 치료하기 위한조성물과 방법
KR20080034905A (ko) 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법
CN101272800A (zh) 使用铜氧还蛋白控制血管发生的组合物和方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090410

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid